Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurobiology and Treatment of Reading Disability in Neurofibromatosis Type 1 (NF-1)

NCT00624234 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00624234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00624234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurobiology and Treatment of Reading Disability in Neurofibromatosis Type 1 (NF-1)
Lead sponsor
Vanderbilt University
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2006
Completion date
January 31, 2017
Enrollment
184 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 1, reading disabilities